NASDAQ: LAB
Standard Biotools Inc Stock Forecast, Predictions & Price Target

Analyst price target for LAB

Based on 1 analyst offering 12 month price targets for Standard Biotools Inc

Min Forecast
$2.50+77.3%
Avg Forecast
$2.50+77.3%
Max Forecast
$2.50+77.3%

Should I buy or sell LAB stock?

Based on 1 analyst offering ratings for Standard Biotools Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although LAB's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates LAB as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their LAB stock forecasts and price targets.

LAB stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-10-31

1 of 1

Forecast return on equity

Is LAB forecast to generate an efficient return?

Company
N/A
Industry
-9.83%
Market
222.65%

Forecast return on assets

Is LAB forecast to generate an efficient return on assets?

Company
N/A
Industry
10.67%

LAB earnings per share forecast

What is LAB's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$0.24

LAB revenue forecast

What is LAB's revenue in the next 1 years based on estimates from 2 analysts?

Avg 1 year Forecast
$182.9M+17.32%
LAB's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

LAB revenue growth forecast

How is LAB forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
17.32%
Industry
9.12%
Market
19.67%
LAB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
LAB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

LAB vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
LAB$1.41$2.50+77.30%Strong Buy
FLGT$16.90$22.00+30.18%Hold
PSNL$5.51$7.81+41.80%Strong Buy
CSTL$27.32$40.00+46.41%Strong Buy
ACRS$2.33$11.00+372.10%Strong Buy

Standard Biotools Stock Forecast FAQ

Is Standard Biotools Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: LAB) stock is to Strong Buy LAB stock.

Out of 1 analyst, 1 (100%) are recommending LAB as a Strong Buy, 0 (0%) are recommending LAB as a Buy, 0 (0%) are recommending LAB as a Hold, 0 (0%) are recommending LAB as a Sell, and 0 (0%) are recommending LAB as a Strong Sell.

If you're new to stock investing, here's how to buy Standard Biotools stock.

What is LAB's earnings growth forecast for 2025-2025?

(NASDAQ: LAB) Standard Biotools's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 46.91%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 65.95%.

Standard Biotools's earnings in 2025 is -$170,603,000.

In 2025, LAB is forecast to generate -$89,342,112 in earnings, with the lowest earnings forecast at -$89,342,112 and the highest earnings forecast at -$89,342,112.

What is LAB's revenue growth forecast for 2025-2025?

(NASDAQ: LAB) Standard Biotools's forecast annual revenue growth rate of 17.32% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 9.12%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 19.67%.

Standard Biotools's revenue in 2025 is $155,902,000.

In 2025, LAB is forecast to generate $68,086,134,154 in revenue, with the lowest revenue forecast at $67,304,390,678 and the highest revenue forecast at $68,867,877,630.

What is LAB's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: LAB) forecast ROA is N/A, which is lower than the forecast US Diagnostics & Research industry average of 10.67%.

What is LAB's Price Target?

According to 1 Wall Street analyst that have issued a 1 year LAB price target, the average LAB price target is $2.50, with the highest LAB stock price forecast at $2.50 and the lowest LAB stock price forecast at $2.50.

The Wall Street analyst predicted that Standard Biotools's share price could reach $2.50 by Oct 31, 2025. The average Standard Biotools stock price prediction forecasts a potential upside of 77.3% from the current LAB share price of $1.41.

What is LAB's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: LAB) Standard Biotools's current Earnings Per Share (EPS) is -$0.71. In 2025, LAB's EPS is forecast to hit -$0.24 (min: -$0.24, max: -$0.24).

What is LAB's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: LAB) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.